These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term cannabis abuse and early-onset cannabis use increase the severity of cocaine withdrawal during detoxification and rehospitalization rates due to cocaine dependence. Viola TW; Tractenberg SG; Wearick-Silva LE; Rosa CS; Pezzi JC; Grassi-Oliveira R Drug Alcohol Depend; 2014 Nov; 144():153-9. PubMed ID: 25262527 [TBL] [Abstract][Full Text] [Related]
23. Made from concentrate? A national web survey assessing dab use in the United States. Sagar KA; Lambros AM; Dahlgren MK; Smith RT; Gruber SA Drug Alcohol Depend; 2018 Sep; 190():133-142. PubMed ID: 30029166 [TBL] [Abstract][Full Text] [Related]
24. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Trigo JM; Lagzdins D; Rehm J; Selby P; Gamaleddin I; Fischer B; Barnes AJ; Huestis MA; Le Foll B Drug Alcohol Depend; 2016 Apr; 161():298-306. PubMed ID: 26925704 [TBL] [Abstract][Full Text] [Related]
25. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment. Connor JP; Gullo MJ; Feeney GF; Young RM Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593 [TBL] [Abstract][Full Text] [Related]
26. Heritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian community. Ehlers CL; Gilder DA; Gizer IR; Wilhelmsen KC Addict Biol; 2009 Jul; 14(3):338-48. PubMed ID: 19413562 [TBL] [Abstract][Full Text] [Related]
27. Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Int J Methods Psychiatr Res; 2013 Jun; 22(2):138-43. PubMed ID: 23670783 [TBL] [Abstract][Full Text] [Related]
28. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016. Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323 [TBL] [Abstract][Full Text] [Related]
29. If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Hickman M; Vickerman P; Macleod J; Lewis G; Zammit S; Kirkbride J; Jones P Addiction; 2009 Nov; 104(11):1856-61. PubMed ID: 19832786 [TBL] [Abstract][Full Text] [Related]
30. Blurred boundaries: the therapeutics and politics of medical marijuana. Bostwick JM Mayo Clin Proc; 2012 Feb; 87(2):172-86. PubMed ID: 22305029 [TBL] [Abstract][Full Text] [Related]
31. A comparison of the latent class structure of cannabis problems among adult men and women who have used cannabis repeatedly. Grant JD; Scherrer JF; Neuman RJ; Todorov AA; Price RK; Bucholz KK Addiction; 2006 Aug; 101(8):1133-42. PubMed ID: 16869843 [TBL] [Abstract][Full Text] [Related]
32. The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics. van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M Int J Methods Psychiatr Res; 2011 Sep; 20(3):169-81. PubMed ID: 21815231 [TBL] [Abstract][Full Text] [Related]
33. Interrelationships between marijuana demand and discounting of delayed rewards: Convergence in behavioral economic methods. Aston ER; Metrik J; Amlung M; Kahler CW; MacKillop J Drug Alcohol Depend; 2016 Dec; 169():141-147. PubMed ID: 27810657 [TBL] [Abstract][Full Text] [Related]
34. [Cannabis cessation interventions offered to young French users: predictors of follow-up]. Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272 [TBL] [Abstract][Full Text] [Related]
35. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls]. Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871 [TBL] [Abstract][Full Text] [Related]
36. Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design. Hines LA; Morley KI; Rijsdijk F; Strang J; Agrawal A; Nelson EC; Statham D; Martin NG; Lynskey MT Psychol Med; 2018 Dec; 48(16):2786-2793. PubMed ID: 29530110 [TBL] [Abstract][Full Text] [Related]
37. Potency of Δ Potter DJ; Hammond K; Tuffnell S; Walker C; Di Forti M Drug Test Anal; 2018 Apr; 10(4):628-635. PubMed ID: 29441730 [TBL] [Abstract][Full Text] [Related]
38. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917 [TBL] [Abstract][Full Text] [Related]
39. Cross-domain correlates of cannabis use disorder severity among young adults. Schuster RM; Hareli M; Moser AD; Lowman K; Gilman J; Ulysse C; Schoenfeld D; Evins AE Addict Behav; 2019 Jun; 93():212-218. PubMed ID: 30753972 [TBL] [Abstract][Full Text] [Related]
40. The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence. Hines LA; Morley KI; Strang J; Agrawal A; Nelson EC; Statham D; Martin NG; Lynskey MT Addiction; 2015 Aug; 110(8):1311-20. PubMed ID: 25917230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]